The Institute for Research in Biomedicine was founded in 2000 with the goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense.

The IRB benefits from a wide international network of collaborations.

In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.

NewsAll news

	12.02.2019 New study by the Monticelli’s lab on epigenetic modifications in human T cells This study, performed primarily by Lucia Vincenzetti, was recently published in the European Journal of Immunology. Epigenetic modifications such as DNA methylation are... Read more
	07.02.2019 Pfizer Foundation Research Prize 2019 – accolades for researchers in Ticino This evening, at a ceremony held in Zurich, the Pfizer Foundation awarded two prizes to research groups at the Institute for Research in Biomedicine (IRB) and at the... Read more
	25.01.2019 Ebola: Promising Early-Stage Safety Clinical Trial Results For Potential Treatment Based On Antibodies Isolated In Tessin A Phase 1 clinical trial to test the safety of an antibody to use against Ebola outbreak has been successfully concluded by the National Institutes of Health (NIH)... Read more
	23.01.2019 New Study from the Grassi’s lab on the discovery of a checkpoint regulator of pathogenic T lymphocytes in systemic lupus erythematosus Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect different organs, including kidney, skin, heart, lung and nervous system. The mechanisms... Read more
	16.01.2019 A new generation of oral vaccines by inhibiting microbiota-derived ATP in the intestine Enteric infections affect up to 1 billion people leading to 2 million deaths per year worldwide. No effective vaccines exist against major enteric pathogens, including... Read more